Excellent response of a  disseminated SMARCA4-deficient thoracic sarcomatoid tumor to immunochemotherapy—a case report

SummaryA  68-year-old man was diagnosed with a SMARCA4-deficient thoracic sarcomatoid tumor. Immunochemotherapy with carboplatin, paclitaxel, and pembrolizumab followed by maintenance therapy with pembrolizumab resulted in clinically meaningful remission.
Source: Memo - Magazine of European Medical Oncology - Category: Cancer & Oncology Source Type: research